Genomic epidemiology of erythromycin-resistant Bordetella pertussis in China

Macrolides such as erythromycin are the empirical treatment of Bordetella pertussis infections. China has experienced an increase in erythromycin-resistant B. pertussis isolates since they were first reported in 2013. Here, we undertook a genomic study on Chinese B. pertussis isolates from 2012 to 2...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Zheng, Wang, Zengguo, Luan, Yang, Li, Yarong, Liu, Xiaoguai, Peng, Xiaokang, Octavia, Sophie, Payne, Michael, Lan, Ruiting
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6455148/
https://www.ncbi.nlm.nih.gov/pubmed/30898080
http://dx.doi.org/10.1080/22221751.2019.1587315

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6455148/
https://www.ncbi.nlm.nih.gov/pubmed/30898080
http://dx.doi.org/10.1080/22221751.2019.1587315

Ejemplares similares